Psychiatric Professionals of Georgia, powered by Geode Health
3500 Parkway Lane, 430, Norcross
4.7(124 Google reviews)
United States
2 listed treatment centers serving Peachtree Corners and the surrounding area.
3500 Parkway Lane, 430, Norcross
4.7(124 Google reviews)
4720 Peachtree Industrial Boulevard, Suite 4101, Norcross
3.2(35 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Peachtree Corners.
1.9 miles away · Norcross
4720 Peachtree Industrial Boulevard, Suite 4101, Norcross
4.7(53 Google reviews)
4.4 miles away · Johns Creek
4.4 miles away · Johns Creek
10090 Medlock Bridge Road, Suite 110, Johns Creek
4.2(684 Google reviews)
4.4 miles away · Johns Creek
10090 Medlock Bridge Road, Suite 110, Johns Creek
4.6(34 Google reviews)
4.4 miles away · Johns Creek
10090 Medlock Bridge Road, Suite 110, Johns Creek
4.6(22 Google reviews)
4.4 miles away · Johns Creek
10090 Medlock Bridge Road, Suite 110, Johns Creek
4.5(49 Google reviews)
For people in Peachtree Corners, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and how services are billed. The medication and the visit for administration and observed monitoring may generate separate charges. Ask for an estimate that includes both, rather than a medication-only quote.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medications you took, how long you took them, and your response. The treatment center can explain what documentation it needs from your current or previous prescribers. An initial consultation does not guarantee authorization or payment.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Georgia Medicaid coverage also depends on the applicable plan and its requirements. Confirm both the center’s participation and your specific benefits; a directory listing is not proof that a center accepts your insurance.
Manufacturer savings programs exist for eligible commercially insured patients, but eligibility rules apply, and these savings programs are not for people using government insurance such as Medicare or Medicaid. Ask the center about current requirements without assuming you qualify.
Before starting, ask the center and insurer:
Include transportation and time away from work in your budget, even though those are separate from medical bills.
SPRAVATO® is given only in a healthcare setting certified through the SPRAVATO® REMS safety program. You self-administer the nasal spray under a healthcare provider’s direct observation; it is never dispensed for home use. Monitoring continues for at least two hours after each dose, so allow additional time for check-in, preparation, and any longer observation your care team recommends.
For treatment-resistant depression, the typical labeled schedule is twice weekly during weeks 1–4, weekly during weeks 5–8, and then weekly or every two weeks. Your prescriber individualizes the schedule; do not assume that a particular frequency is guaranteed.
Arrange for someone else to drive you home after every appointment. You must not drive or operate machinery until the next day after a restful sleep. Before booking, ask the center about its transportation and pickup requirements. If you plan to use a taxi or rideshare, check whether an accompanying adult is required. Have a backup ride in case your usual driver becomes unavailable.
When planning work, reserve time for the entire appointment and transportation, and discuss any driving or machinery duties with your care team. Scheduling help with caregiving responsibilities may also make treatment days easier to manage.
If you cannot find a confirmed center within Peachtree Corners, the supplied directory records include listings in Norcross, with additional listings in Atlanta, Johns Creek, Alpharetta, and Roswell. The Norcross records identify Spravato services but do not confirm REMS certification. Contact any prospective center directly to verify certification, current appointment availability, and insurance participation before arranging travel.
Start with directory listings, then contact the center to confirm current SPRAVATO® REMS certification and whether it is accepting new patients. The supplied records include Norcross listings offering Spravato, but their certification status is not confirmed. Other listed cities include Johns Creek, Alpharetta, Roswell, and Atlanta. A listing alone does not establish certification, appointment availability, or insurance acceptance.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A prescriber must review your symptoms, treatment history, and medical risks to determine whether it is appropriate for you.
Coverage depends on your plan, the treatment setting, and authorization requirements. Insurers commonly request documentation of previous antidepressant trials. Ask about coverage for both the medication and the monitored visit, along with network status and your share of costs. Medicare and Georgia Medicaid may cover treatment depending on the plan and setting, but not every center accepts them. Confirm benefits before starting.
You use the nasal spray yourself while a healthcare provider directly observes you in a REMS-certified setting. Staff monitor you for at least two hours afterward for effects such as sedation, dissociation, breathing problems, and blood pressure increases. You may need longer observation. Arrange for someone else to drive you home, and do not drive until the next day after a restful sleep.
Discuss sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Share your medical history and all medicines you take so the prescriber can assess risks and explain what to report during and after treatment.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Do not wait for an evaluation or treatment appointment during a crisis. Call or text 988 for immediate crisis support, or call 911 in an emergency. Tell your care team promptly about new or worsening suicidal thoughts.
Approved uses, nearby treatment centers, and medically sourced patient guides.